Get started
Author

Cecilia Isaksson

Observed names: C. Isaksson, Isaksson, Cecilia
ORCID: 0000-0002-6510-2898
Observed ORCID: 0000-0002-6510-2898
OpenAlex ID: A5014167441
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
2014 · Joachim Burman, Ellen Iacobaeus, et al. · Journal of Neurology Neurosurgery & Psychiatry · 166
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
2018 · Mohamed A. Kharfan-Dabaja, Myriam Labopin, et al. · JAMA Oncology · 164
PDF
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000–2011
2017 · Krista Vaht, Magnus Göransson, et al. · Haematologica · 107
PDF
Melphalan 140 mg/m 2 or 200 mg/m 2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party
2017 · Holger W. Auner, Simona Iacobelli, et al. · Haematologica · 92
PDF
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP
2013 · R. Press, H. Askmark, et al. · Journal of Neurology Neurosurgery & Psychiatry · 61
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry
2019 · Anna Lübking, Arta Dreimane, et al. · Bone Marrow Transplantation · 52
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation
2018 · Simone Cesaro, Gloria Tridello, et al. · Clinical Infectious Diseases · 40
PDF
Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT
2019 · Martin Schmidt-Hieber, Dan Engelhard, et al. · Journal of Neurology · 23
Low response rate to ATG ‐based immunosuppressive therapy in very severe aplastic anaemia — A Swedish nationwide cohort study
2018 · Krista Vaht, Magnus Göransson, et al. · European Journal Of Haematology · 22
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
2018 · Firoozeh Sahebi, Simona Iacobelli, et al. · Transplantation and Cellular Therapy · 17
PDF
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT
2022 · Rafal Machowicz, Felipe Suarez, et al. · Bone Marrow Transplantation · 16
PDF
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study
2019 · Krista Vaht, Magnus Göransson, et al. · Transplantation and Cellular Therapy · 15
PDF
Allogeneic stem cell transplantation for acquired pure red cell aplasia
2019 · Constantijn Halkes, Liesbeth C de Wreede, et al. · American Journal of Hematology · 14
PDF
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
2020 · Sebastian Giebel, Myriam Labopin, et al. · Bone Marrow Transplantation · 13
Allogeneic Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis (HLH) in Adults: A Retrospective Study of the Chronic Malignancies and Inborn Errors Working Parties (CMWP and IEWP) of the EBMT
2016 · Rafal Machowicz, Felipe Suarez, et al. · Blood · 6
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
2024 · Matjaz Sever, Joanna Drozd-Sokolowska, et al. · Bone Marrow Transplantation · 5
Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
2024 · Dina Averbuch, Gloria Tridello, et al. · Transplantation and Cellular Therapy · 5
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study
2021 · Sarah Lawless, Giulia Sbianchi, et al. · Clinical Lymphoma Myeloma & Leukemia · 5
PDF
Incidence and Outcome in Aplastic Anemia Diagnosed 2000-2011 - a Nationwide Swedish Registry Study
2016 · Krista Vaht, Magnus Göransson, et al. · Blood · 1
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Neoplasms with Accompanying Paroxysmal Nocturnal Hemoglobinuria - a Study on Behalf of Cmwp and Saawp of the EBMT
2024 · Joanna Drozd-Sokolowska, Patrick Gilbert, et al. · Blood
PDF
Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres between 2012 and 2021
2022 · Patrick John Hayden, Dirk-Jan Eikema, et al. · Blood
Prognostic impact of early‐versus‐late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT
2021 · Laurent Garderet, Giulia Sbianchi, et al. · European Journal Of Haematology
Outcome of the Rare Myeloma Subtypes- An Analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) Data
2017 · Sarah Lawless, Curly Morris, et al. · Clinical Lymphoma Myeloma & Leukemia
The impact of melphalan dosage on outcomes of autologous haematopoietic cell transplantation for multiple myeloma: Results from the EBMT collaboration to collect autologous transplant outcomes in lymphoma and myeloma (CALM) study
2017 · Holger W. Auner, Stefano Iacobelli, et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
Recent results of allogeneic stem cell transplantation for myelofibrosis using reduced intensity conditioning - the Swedish experience
2015 · Stig Lenhoff, Arta Dreimane, et al. · Bone Marrow Transplantation
Works count: 28
Citation count: 824
H-index: 13
I10-index: 14
Year
Topic
Type